Schonfeld Strategic Advisors’s Cabaletta Bio CABA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$75.8K	Sell	28,172 -1,175,898	-98%	-$3.27M	﹤0.01%	1923
2025 Q4	$2.64M	Buy	1,204,070 +159,901	+15%	+$396K	0.01%	779
2025 Q3	$2.44M	Sell	1,044,169 -440,667	-30%	-$756K	0.01%	931
2025 Q2	$2.26M	Sell	1,484,836 -177,565	-11%	-$277K	0.02%	917
2025 Q1	$2.3M	Buy	+1,662,401	New	+$3.54M	0.01%	892
2024 Q3	–	Sell	-194,037	Closed	-$1.45M	–	2068
2024 Q2	$1.45M	Sell	194,037 -123,483	-39%	-$1.51M	0.01%	1046
2024 Q1	$5.42M	Buy	317,520 +65,905	+26%	+$1.41M	0.04%	618
2023 Q4	$5.71M	Buy	+251,615	New	+$4.23M	0.04%	494

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Schonfeld Strategic Advisors's CABA Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Cabaletta Bio (CABA) stake by 98% in Q1 2026, selling an estimated $3.27M and leaving 28,172 shares worth $75.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

Schonfeld Strategic Advisors first reported a position in CABA in Q4 2023 and has held it in 8 quarters since. The position peaked at $5.71M in Q4 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

Schonfeld Strategic Advisors held 28,172 shares of Cabaletta Bio worth $75.8K as of Q1 2026.
Schonfeld Strategic Advisors sold 1,175,898 Cabaletta Bio shares in Q1 2026, an estimated $3.27M.
Cabaletta Bio made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1923 holding.
Schonfeld Strategic Advisors first reported a position in Cabaletta Bio in Q4 2023 and has held it in 8 quarters since.
Schonfeld Strategic Advisors's Cabaletta Bio position peaked at $5.71M in Q4 2023.
108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.